dystrophy

Showing 1 posts of 1 posts found.

Biomarin image

BioMarin to buy Prosensa in $840 million deal

November 25, 2014
Sales and Marketing BioMarin, Prosensa, drisapersen, dystrophy

Rare-disease drug firm BioMarin has finalised its purchase of muscular disease specialist Prosensa in a deal worth over $840 million. …

The Gateway to Local Adoption Series

Latest content